Carl Zeiss Meditec Receives German Innovation Award
(Thomson Reuters ONE) -
Carl Zeiss Meditec AG /
Carl Zeiss Meditec Receives German Innovation Award
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Honor for the INTRABEAM(®) intraoperative radiotherapy system - on the road to a
new standard in the treatment of breast cancer
JENA - 28 March 2011
Medical systems supplier Carl Zeiss Meditec has been honored with the German
Innovation Award for its INTRABEAM(® )radiotherapy system. Clinical studies have
verified the potential of reducing the up-to-six-week radiotherapy of breast
cancer patients to a single, approximately 30-minute boost during the operation.
The top-notch jury was impressed by this as well as the emerging market success.
Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG: "INTRABEAM is a
prime example of how we can contribute to medical advances with innovations.
Receiving the German Innovation Award fills us with pride and further
demonstrates that we are on the right track with our strategy."
Dr. Dietrich Wolf, Director of the Radiotherapy Business Unit at Carl Zeiss
Meditec AG: "I am delighted that the many years of research and development work
we put in together with our clinical partners are paying off. The continuous
dialog with our customers played a key role. INTRABEAM enables new approaches to
the treatment of cancer and is a product with real added value for patients,
doctors and cost carriers in the healthcare system."
Prof. Dr. Frederik Wenz from the University Hospital in Mannheim, one of the
pioneers in treatment with INTRABEAM: "The value of the INTRABEAM system for
clinical application is enormous. Primarily for the patients, therapy with
INTRABEAM means a gentler and shorter treatment: the one-time intraoperative
irradiation preserves the surrounding tissue during the procedure and minimizes
the dose on the skin. Furthermore, the reduction of the irradiation period from
six weeks to one day, and the corresponding elimination of long travel times
lead to financial savings for the cost carriers."
Innovation with verified effectiveness
In recent years, the intraoperative boost with the INTRABEAM system was compared
to the multi-week treatment standard during the independent, international
TARGIT-A study. More than 2000 patients took part in the study, which
demonstrated that the new treatment method with INTRABEAM is not inferior to the
multi-week external irradiation method for the selected group of patients. The
study results were published in The Lancet medical journal and since then have
received a lot of feedback in the international trade press.
The German Innovation Award
The German Innovation Award is presided over by the German Federal Ministry of
Economics and was initiated by Accenture, EnBW, Evonik and WirtschaftsWoche
magazine with the objective of honoring the outstanding, pioneering innovations
of German companies. The awards ceremony was held on 25 March in Munich. Carl
Zeiss Meditec was honored in the category "medium-sized business".
--- End of Message ---
Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany
WKN: 531370;ISIN: DE0005313704;Index:Prime All Share,TECH All Share,TecDAX;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Carl Zeiss Meditec AG via Thomson Reuters ONE
[HUG#1500708]
Unternehmensinformation / Kurzprofil:
Datum: 28.03.2011 - 09:07 Uhr
Sprache: Deutsch
News-ID 52852
Anzahl Zeichen: 4518
contact information:
Town:
Jena
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 241 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Carl Zeiss Meditec Receives German Innovation Award"
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
